ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 720438 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 720438; 2) Community: the network communities that were significantly associated with the response to NSC 720438; 3) Molecule: the relationships between components within communities and NSC 720438; 4) MDR: the compounds that were significantly associated with the NSC 720438.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0126882509540134 0.23168665
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0126882509540134 0.4858114
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0126882509540134 0.42070135
NSC 603071 Aminocamptothecin 0.0126882509540134 0.39374098
NSC 606497 Camptothecin Derivative 0.0126882509540134 0.42906322
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0126882509540134 0.33956665
NSC 666126 Null 0.0126882509540134 0.32628349
NSC 673652 2-Ethylaminoestradiol 0.0126882509540134 -0.014665861
NSC 683766 Benzoic acid, 4-[[(2-bromi-3,6-dioxo-1,4-cyclohexadienyl)methyl]-amino]-, 1-adamantyl ester 0.0126882509540134 0.23151021
NSC 683833 Null 0.0126882509540134 0.37424379
Total:53  Current:14    [First] [Prev] [Next] [Last]